June 14, 2021
Pii Blog
Michelle Ava, Sales & Digital Marketing Systems Administrator
BACK TO RESOURCE CENTER Other Content Guide to Aseptic ManufacturingArticlesBlogsCase StudiesMeet the... See more »
450 Followers on Owler
Recipharm
Recipharm is a contract development and manufacturing organization specializing in pharmaceutical products. Read more
CEO
Marc Funk
Founded:
1995
SIC Code:
Website:
Missing a competitor? Contribute!
DPT Laboratories is one of Recipharm's top competitors. DPT Laboratories was founded in 1938 in San Antonio, Texas. DPT Laboratories operates in the Pharmaceuticals industry. DPT Laboratories generates $1.3B less revenue than Recipharm.
WellSpring Pharma Services, Inc. is a top competitor of Recipharm. WellSpring Pharma Services, Inc. was founded in 2001, and is headquartered in Oakville, Ontario. WellSpring Pharma Services, Inc. is in the Pharmaceuticals industry. WellSpring Pharma Services, Inc. generates $1.3B less revenue vs. Recipharm.
Weigh-in!
Help the Owler community know moreTrending News for Recipharm and Recipharm's Competitors
Recipharm Acquisitions
COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Consort Medical Plc
Nov 2019
Source »$649M
Consort Medical is a contract developer and manufacturer of drug delivery devices that include nasal inhalers and pharmaceutical compounds.
-
Kemwell’s Pharmaceutical Contract Development and Manufacturing (CDMO) Businesses, U.S. and Swedish Operations
Apr 2016
Source »$205M
-
Mitim S.r.l.
Feb 2016
Source »$75.5M
Mitim develops and manufactures beta lactams in dry sterile powder for injectable solutions, tablets and oral suspensions.
These are all the companies that Recipharm has acquired. Recipharm has acquired 9 companies and its latest acquisition was Consort Medical Plc in Nov 2019. Consort Medical is a contract developer and manufacturer of drug delivery devices that include nasal inhalers and pharmaceutical compounds.
Recipharm Funding History
Since Recipharm was founded in 1995, it has participated in 6 rounds of funding. In total Recipharm has raised $797.0M. Recipharm's last funding round was on May 2020 for a total of $51.1M
ROUND
FUNDING DATE
AMOUNT
INVESTORS
Post-IPO Debt
May 2020
$51.1M
-
Post-IPO Debt
May 2018
$58.9M
-
Post-IPO Equity
Jan 2016
$32M
-
IPO
Apr 2014
$432.3M
-
Since Recipharm was founded in 1995, it has participated in 6 rounds of funding. In total Recipharm has raised $797.0M. Recipharm's last funding round was on May 2020 for a total of $51.1M
Recipharm Investments
FOLLOW STATUS
COMPANY
DESCRIPTION
AMOUNT
INVESTMENT DATE
ROUND
EXIT DATE
These are all the companies that Recipharm has invested in. Recipharm has invested 9 companies and its latest investment was Consort Medical Plc in Nov 2019. Consort Medical is a contract developer and manufacturer of drug delivery devices that include nasal inhalers and pharmaceutical compounds.
Recipharm News
February 12, 2021The Pharma Letter
BRIEF-EC clears the acquisition of joint control of Recipharm
The European Commission has approved, under the EU Merger Regulation, the acquisition of joint contro... See more »
February 8, 2021Contract Pharma
Recipharm and Medspray Complete Joint Venture
Aim to utilize novel softmist technology for pharmaceutical applications.... See more »
January 21, 2021Manufacturing Chemist
Recipharm and binx announce long-term supply agreement
Recipharm is a minority investor in binx health... See more »
January 21, 2021Contract Pharma
Recipharm Signs Manufacturing Deal with Enzymatica
Agreement will involve an additional Recipharm production site in Pianezza, Italy.... See more »
January 13, 2021Manufacturing Chemist
Recipharm signs manufacturing agreement with Enzymatica
ColdZyme is intended to treat and alleviate common cold and has already been launched in about 30 cou... See more »
January 7, 2021FiercePharma
Moderna teams with Sweden's Recipharm to rev up EU vaccine manufacturing
Moderna teams with Sweden's Recipharm to rev up EU vaccine manufacturing fkansteiner Thu, 01/07/2021 ... See more »
January 4, 2021Manufacturing Chemist
Recipharm and Moderna sign fill-finish agreement
Subject to regulatory approval of the vaccine in relevant countries outside of the US, supply is expe... See more »
Recipharm Press Releases
February 4, 2021Cision
Roar BidCo's outstanding public offer for Recipharm AB (publ) - Consent granted to correct error in the Convertible Bond Terms
On 14 December 2020, EQT IX1 ("EQT IX"), through Roar BidCo AB2 ("Roar BidCo"), announced a... See more »
February 1, 2021B3C Group
Recipharm and Medspray Launch Resyca Joint Venture to Exploit Novel Softmist Technology for Pharmaceutical Applications
ENSCHEDE, the Netherlands, February 01, 2021 / B3C newswire / -- Recipharm AB (publ) ("Recipharm"), a... See more »
January 11, 2021Cision
XS1496895753)
THIS ANNOUNCEMENT RELATES TO THE DISCLOSURE OF INFORMATION THAT QUALIFIED OR MAY HAVE QUALIFIED... See more »
January 11, 2021Cision
Recipharm has convened a bondholder meeting to correct the terms and conditions of its convertible bonds and announces date for a preliminary 2020 year-end report
FOR DISTRIBUTION ONLY OUTSIDE THE UNITED STATES TO PERSONS OTHER THAN "U.S. PERSONS" (AS DEFINED... See more »
October 13, 2020Cision
Recipharm invests EUR 2.6 million in Kaysersberg facility
Global contract development and manufacturing organisation (CDMO), Recipharm, has announced a EUR... See more »
August 13, 2020Presswire
Complete contents of Recipharm's Ashton-under Lyne pharmaceutical manufacturing facility under the hammer
Complete contents of Recipharm's Ashton-under Lyne pharmaceutical manufacturing facility under the ha... See more »
July 31, 2020Cision
Change in the total number of shares and votes in Recipharm AB (publ)
As of 31 July 2020, the total number of shares in Recipharm AB (publ) ("Recipharm") amounts to... See more »
Recipharm Videos
October 26, 2020Recipharm Youtube Channel
"Webinar: Moving from device concept to commercial - industrialising with technology" on YOUTUBE
June 23, 2020Recipharm Youtube Channel
"The Recipharm journey: 25 years of profitable growth" on YOUTUBE
Social Media
Recipharm Headquarters
Trending Companies
IN THE NEWS
Rightpoint | FleetCor | Qualcomm | Cohesionmarketingpartners | Arco Platform | Albemarle | Monster Beverage | Eclipse | NASA | AIA Chicago | Hain Celestial | Coastal Federal Credit Union | Danaher | Sensata | Turquoise Hill | Nokia | Dick's | McLane | Johnson & Johnson | Five9 | Brookfield Asset Management | Akcea Therapeutics | Johnson Controls | molzi | Schall Law Firm | Xaar | Ross Stores | Tricida | Lendified | Suzlon | Six Flags | McDonald's | Cousins Furniture Stores | MAA | T-Mobile | Eagle Materials | Constellation Brands | Vanguard | ChainLink | Northland Rehab Supply | Pantheon | Neuralink | Oracle | AutoZone | Edwards | Progenity | McKibbon | GenMark | Capitan Mining | Electronic Arts
PEOPLE ALSO VIEWED
Datar Genetics | ShapeUp, Inc. | Coventry Health Care | Portea | Somnia, Inc. | Zimmer Biomet | Covenant Health | Allscripts | Iora Health | Oxford Nanopore | Sonic Boom | VLCC Health Care Limited | Gaia Herbs | Team Health Holdings, Inc. | Rhythm Pharmaceuticals, Inc. | Powermat | Yamaha Corporation | Dover Corp. | AKQA | Plex | Wellbe Inc. | Second Sight Medical Products Inc | Stroops | Colibri | The Breathing Class | Harman Kardon | ChemChina | Yumpu.com | SaveRisk | Milo.com, Inc.
Recipharm Summary
ABOUT
Overview
Recipharm is a contract development and manufacturing organization specializing in pharmaceutical products. Recipharm was founded in 1995. Recipharm's headquarters is located in Stockholm, Stockholms län, SE 101 32. It has raised 797.0M in 6 rounds. T...
CEO
Recipharm's CEO, Marc Funk, currently has an approval rating of 82%. Recipharm's primary competitors are DPT Laboratories, WellSpring Pharma Services, Inc. & PharmaTech.Website
recipharm.comFrequently Asked Questions about Recipharm
When was Recipharm founded?
Recipharm was founded in 1995Who is Recipharm's CEO?
Recipharm's CEO is Marc FunkHow much revenue does Recipharm generate?
Recipharm generates $1.4B in revenueHow much funding does Recipharm have?
Recipharm has historically raised $797M in funding
Where is Recipharm's headquarters?
Recipharm's headquarters is in Stockholm Stockholms län, SEHow many employees does Recipharm have?
Recipharm has 7,857 employeesWho are Recipharm's competitors?
Recipharm's top competitors are DPT Laboratories, WellSpring Pharma Services, Inc., PharmaTechWho has Recipharm invested in?
Recipharm's has invested in companies such as Liddspharma, Pharmanest, Synthonics
